The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of the GATA3 rs3824662A allele with clinical outcomes in adult patients with adult B-ALL.
 
Paul B. Koller
No Relationships to Disclose
 
Hagop M. Kantarjian
Honoraria - Abbvie; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer
Research Funding - Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
 
Elias Jabbour
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Astellas Pharma; Bristol-Myers Squibb; Incyte; Pfizer; Takeda
Research Funding - Abbvie; Adaptive Biotechnologies; Amgen; Pfizer; Takeda
 
Sherry A. Pierce
No Relationships to Disclose
 
Kathryn Roberts
No Relationships to Disclose
 
Hui Zhang
No Relationships to Disclose
 
Wenjian Yang
No Relationships to Disclose
 
Charles Grenfell Mullighan
Honoraria - Amgen; Incyte
Consulting or Advisory Role - Incyte
Speakers' Bureau - Amgen
Research Funding - Loxo
Patents, Royalties, Other Intellectual Property - Inventor on a pending patent application related to gene-expression signatures for detection of underlying Philadelphia chromosome–like events and therapeutic targeting in leukemia (PCT/US2012/069228).
Travel, Accommodations, Expenses - Amgen; Incyte
 
Jun J. Yang
No Relationships to Disclose
 
Marina Konopleva
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Abbvie; Calithera Biosciences; Genentech
Consulting or Advisory Role - AbbVie; Cellectis; Genentech/Roche; Stemline Therapeutics
Research Funding - Abbvie (Inst); Ablynx (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Genentech (Inst); Lilly (Inst); Roche (Inst); Stemline Therapeutics (Inst)
 
Nitin Jain
Honoraria - Adaptive Biotechnologies; ADC Therapeutics; Novartis; Novimmune; Pfizer; Pharmacyclics; SERVIER
Consulting or Advisory Role - Adaptive Biotechnologies; ADC Therapeutics; Novartis; Novimmune; Pfizer; Pharmacyclics; SERVIER
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Pfizer (Inst); Pharmacyclics (Inst); Seagen (Inst); SERVIER (Inst)